Response to Office Action

VISTAAR

DDi - Drug Development informatics

Response to Office Action

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1957 (Rev 10/2011)
OMB No. 0651-0050 (Exp 09/20/2020)

Response to Office Action


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88209151
LAW OFFICE ASSIGNED LAW OFFICE 125
MARK SECTION
MARK FILE NAME http://uspto.report/TM/88209151/mark.png
LITERAL ELEMENT VISTAAR
STANDARD CHARACTERS NO
USPTO-GENERATED IMAGE NO
GOODS AND/OR SERVICES SECTION (current)
INTERNATIONAL CLASS 042
DESCRIPTION
Vistaar is a global regulatory and clinical intelligence platform that combines up to date regulatory content compiled by experts with advanced technology of Artificial Intelligence - AI to deliver a unique regulatory intelligence solution that is both fast and cost-effective. It applies Artificial Intelligence to extract information by automatically fetching, classifying and clustering data and documents into applicable categories like Clinical, Marketing, Lifecycle, Manufacturing, Labeling, Safety and other key areas based on the inbuilt proprietary algorithms that align with regulatory and clinical business goals
FILING BASIS Section 1(a)
        FIRST USE ANYWHERE DATE At least as early as 01/18/2018
        FIRST USE IN COMMERCE DATE At least as early as 01/18/2018
GOODS AND/OR SERVICES SECTION (proposed)
INTERNATIONAL CLASS 042
TRACKED TEXT DESCRIPTION
Vistaar is a global regulatory and clinical intelligence platform that combines up to date regulatory content compiled by experts with advanced technology of Artificial Intelligence - AI to deliver a unique regulatory intelligence solution that is both fast and cost-effective. It applies Artificial Intelligence to extract information by automatically fetching, classifying and clustering data and documents into applicable categories like Clinical, Marketing, Lifecycle, Manufacturing, Labeling, Safety and other key areas based on the inbuilt proprietary algorithms that align with regulatory and clinical business goals; Platform as a service (PAAS) featuring computer software platforms for extracting information by automatically fetching, classifying and clustering data and documents into applicable categories like Clinical, Marketing, Lifecycle, Manufacturing, Labeling, Safety and other key areas based on the inbuilt proprietary algorithms that align with regulatory and clinical business goals using artificial intelligence in the field of global regulatory and clinical intelligence
FINAL DESCRIPTION
Platform as a service (PAAS) featuring computer software platforms for extracting information by automatically fetching, classifying and clustering data and documents into applicable categories like Clinical, Marketing, Lifecycle, Manufacturing, Labeling, Safety and other key areas based on the inbuilt proprietary algorithms that align with regulatory and clinical business goals using artificial intelligence in the field of global regulatory and clinical intelligence
FILING BASIS Section 1(a)
       FIRST USE ANYWHERE DATE At least as early as 01/18/2018
       FIRST USE IN COMMERCE DATE At least as early as 01/18/2018
SIGNATURE SECTION
RESPONSE SIGNATURE /Prasad Gollamudi/
SIGNATORY'S NAME Prasad Gollamudi
SIGNATORY'S POSITION Legal Associate
SIGNATORY'S PHONE NUMBER 888-931-0060
DATE SIGNED 03/12/2019
AUTHORIZED SIGNATORY YES
FILING INFORMATION SECTION
SUBMIT DATE Tue Mar 12 15:07:02 EDT 2019
TEAS STAMP USPTO/ROA-XX.XX.XXX.XXX-2
0190312150702695256-88209
151-6207d909b35acd5ed3362
332a9ec81bb1235dd5746e119
aed59a4a162c661f70d3-N/A-
N/A-20190312144829324603



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1957 (Rev 10/2011)
OMB No. 0651-0050 (Exp 09/20/2020)

Response to Office Action


To the Commissioner for Trademarks:

Application serial no. 88209151 VISTAAR (Stylized and/or with Design, see http://uspto.report/TM/88209151/mark.png) has been amended as follows:

CLASSIFICATION AND LISTING OF GOODS/SERVICES
Applicant proposes to amend the following class of goods/services in the application:
Current: Class 042 for Vistaar is a global regulatory and clinical intelligence platform that combines up to date regulatory content compiled by experts with advanced technology of Artificial Intelligence - AI to deliver a unique regulatory intelligence solution that is both fast and cost-effective. It applies Artificial Intelligence to extract information by automatically fetching, classifying and clustering data and documents into applicable categories like Clinical, Marketing, Lifecycle, Manufacturing, Labeling, Safety and other key areas based on the inbuilt proprietary algorithms that align with regulatory and clinical business goals
Original Filing Basis:
Filing Basis: Section 1(a), Use in Commerce: The applicant is using the mark in commerce, or the applicant's related company or licensee is using the mark in commerce, on or in connection with the identified goods and/or services. 15 U.S.C. Section 1051(a), as amended. The mark was first used at least as early as 01/18/2018 and first used in commerce at least as early as 01/18/2018 , and is now in use in such commerce.

Proposed:
Tracked Text Description: Vistaar is a global regulatory and clinical intelligence platform that combines up to date regulatory content compiled by experts with advanced technology of Artificial Intelligence - AI to deliver a unique regulatory intelligence solution that is both fast and cost-effective. It applies Artificial Intelligence to extract information by automatically fetching, classifying and clustering data and documents into applicable categories like Clinical, Marketing, Lifecycle, Manufacturing, Labeling, Safety and other key areas based on the inbuilt proprietary algorithms that align with regulatory and clinical business goals; Platform as a service (PAAS) featuring computer software platforms for extracting information by automatically fetching, classifying and clustering data and documents into applicable categories like Clinical, Marketing, Lifecycle, Manufacturing, Labeling, Safety and other key areas based on the inbuilt proprietary algorithms that align with regulatory and clinical business goals using artificial intelligence in the field of global regulatory and clinical intelligenceClass 042 for Platform as a service (PAAS) featuring computer software platforms for extracting information by automatically fetching, classifying and clustering data and documents into applicable categories like Clinical, Marketing, Lifecycle, Manufacturing, Labeling, Safety and other key areas based on the inbuilt proprietary algorithms that align with regulatory and clinical business goals using artificial intelligence in the field of global regulatory and clinical intelligence
Filing Basis: Section 1(a), Use in Commerce: The applicant is using the mark in commerce, or the applicant's related company or licensee is using the mark in commerce, on or in connection with the identified goods and/or services. 15 U.S.C. Section 1051(a), as amended. The mark was first used at least as early as 01/18/2018 and first used in commerce at least as early as 01/18/2018 , and is now in use in such commerce.
SIGNATURE(S)
Response Signature
Signature: /Prasad Gollamudi/     Date: 03/12/2019
Signatory's Name: Prasad Gollamudi
Signatory's Position: Legal Associate

Signatory's Phone Number: 888-931-0060

The signatory has confirmed that he/she is not represented by either an authorized attorney or Canadian attorney/agent, and that he/she is either: (1) the owner/holder ; or (2) a person(s) with legal authority to bind the owner/holder; and if an authorized U.S. attorney or Canadian attorney/agent previously represented him/her in this matter, either he/she has filed a signed revocation of power of attorney with the USPTO or the USPTO has granted the request of his/her prior representative to withdraw.

        
Serial Number: 88209151
Internet Transmission Date: Tue Mar 12 15:07:02 EDT 2019
TEAS Stamp: USPTO/ROA-XX.XX.XXX.XXX-2019031215070269
5256-88209151-6207d909b35acd5ed3362332a9
ec81bb1235dd5746e119aed59a4a162c661f70d3
-N/A-N/A-20190312144829324603



uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed